atherosclerosis. 17, 18 Eeg-Olofsson et al. 19 studied a total of 7,454 patients from the Swedish National Diabetes Register over a period of 5 years (aged 20-65 years, diabetes duration 1-35 years) and found a progressively increasing risk of coronary heart disease and cardiovascular diseases with higher HbA1c levels independent of traditional risk factors. HbA1c is a better marker for determining risks of CAD and mortality than fasting blood glucose and even non-diabetic patients with elevated HbA1c levels are also at increased risk for CVD and mortality. 20 Both enhanced inflammation and hyperglycemia contribute to the development and progression of atherosclerosis and are frequently found in patients with clinically advanced disease.
Given the interrelation between inflammation, hyperglycemia, and atherosclerotic disease, we speculated that CRP and HbA1c jointly contribute to the cardiovascular risk of patients with clinically advanced atherosclerotic disease.
Methods:
This cross sectional study was performed on 668 patients of ischemic heart disease (CSA, UA, NSTEMI and STEMI) in the Department of Cardiology, Dhaka Medical College Hospital, Dhaka, who were underwent Coronary angiography from January 2017 to December 2017. The patients' demographic variables, such as age and sex, west and hip circumference and angiography results were recorded. After explaining the aims of the study and obtaining the patient's approval for participation blood samples were sent. CRP value were divided into normal (<6 mg/L), borderline (6-10 mg/L) and high (>10 mg/L) 21 
Results:
This cross sectional study was performed on 668 patients of ischemic heart disease (CSA, UA, NSTEMI and STEMI) in the Department of Cardiology, Dhaka Medical College Hospital, Dhaka, who were underwent Coronary angiography from January 2017 to December 2017.
Most (65.0%) of the patients belonged to age 41-60 years. The mean age was found 51.4±10.7 years with range from 25-85 years. Majority (82.3%) patients were male and 390 (58.4%) patients were illiterate ( Table-I ). In risk factors, highest (40.0%) patients had hypertension followed by 209 (31.3%) diabetes mellitus, 204 (30.5%) smoker, 189 (28.3%) family history of ischemic heart disease and 151 (22.6%) dyslipidemia ( Table-II) . The relationship of HbA1c with the whole spectrum of ischemic heart disease was not statistically significant (p>0.05) but the relationship of CRP with the whole spectrum of ischemic heart disease was statistically significant (p<0.05). Both the relationship of HbA1c and CRP were significantly associated with the severity of coronary artery disease ( Table-V) . At HbA1c e"6.5 percent, severe CAD (double vessel and triple vessel) were found higher in high CRP than normal and borderline CRP group. Which were statistically significant (p<0.05) ( Table-VII) . 
Discussion:
The objective of this study was to identify the CRP as a definite inflammation marker and HbA1c in estimating coronary lesions in patients with the whole spectrum of ischemic heart disease. Although atherosclerosis was formerly considered a bland lipid storage disease, substantial advances in basic and clinical studies have illuminated the role of inflammation and the underlying cellular and molecular mechanisms that contribute to atherogenesis. 4, 23, 24 In this context, accumulating epidemiological data evolved indicating that elevation of CRP heralds atherothrombotic events. [25] [26] [27] [28] In this present study it was observed that most (65.0%) of the patients belonged to age 41-60 years. The mean age was found 51.4±10.7 years with range from 25-85 years. Majority (82.3%) patients were male and 390 (58.4%) patients were illiterate. Similar observation also found by Razban et al. 29 and Muhammad et al. 30 In this study, among the risk factors, highest 267 (40.0%) patients had hypertension followed by 209 (31.3%) diabetes mellitus, 204 (30.5%) smoker, 189 (28.3%) family history of ischemic heart disease and 151 (22.6%) dyslipidemia. This findings were also consistent with others studies. [29] [30] [31] In this study out of 668 patients, 182 (27.2%) patients had chronic stable angina, 129 (19.3%) had unstable angina, 73 (10.9%) had NSTEMI and 284(42.5%) had STEMI. The relationship of CRP with the whole spectrum of ischemic heart 32 and Liuzzo et al. 33 have found that serum levels of hs-CRP increased in both groups of patients with stable angina and unstable angina and this marker is considered as a reliable indicator to predicting future events in these patients. Seyedian et al. 31 also found higher CRP in the unstable angina than stable angina group.
In this study it was observed that the relationship of CRP and HbA1c were significantly associated with the severity of coronary artery disease. Similar result also observed by Haverkate et al. 34 ; Tataru et al. 35 ; Masood et al. 36 and Lee et al. 22 This study observed that at HbA1c e"6.5 percent, severe CAD (double vessel and triple vessel) were found higher in high CRP than normal and borderline CRP, which were statistically significant (p<0.05) and normal coronary artery, in significant CAD and single vessel disease were found non significant. Schillinger et al. 37 reported that hs-CRP and HbA1c jointly as prognostic parameters may help to more adequately identify and better treat highest-risk patients with atherosclerosis.
Conclusion:
Inflammation, presented by CRP and hyperglycemia, presented by HbA1c, jointly contribute to the cardiovascular risk of patients. Patients with high CRP and elevate HbA1c combinedly associated with severe coronary artery diseases.
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